HealthStream (HSTM) Competitors

HealthStream (NASDAQ:HSTM) and Omnicell (NASDAQ:OMCL) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, media sentiment, community ranking, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability.

Does the media refer more to HSTM or OMCL?

In the previous week, Omnicell had 6 more articles in the media than HealthStream. MarketBeat recorded 9 mentions for Omnicell and 3 mentions for HealthStream. HealthStream's average media sentiment score of 1.61 beat Omnicell's score of 1.06 indicating that HealthStream is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthStream	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Omnicell	3 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher valuation and earnings, HSTM or OMCL?

HealthStream has higher earnings, but lower revenue than Omnicell. HealthStream is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthStream	$291.65M	3.52	$15.21M	$0.66	50.91
Omnicell	$1.11B	1.33	$12.53M	$0.27	116.65

Does the MarketBeat Community believe in HSTM or OMCL?

Omnicell received 40 more outperform votes than HealthStream when rated by MarketBeat users. Likewise, 66.80% of users gave Omnicell an outperform vote while only 66.52% of users gave HealthStream an outperform vote.

Company	Underperform	Outperform
HealthStream	Outperform Votes 463 66.52%	Underperform Votes 233 33.48%
Omnicell	Outperform Votes 503 66.80%	Underperform Votes 250 33.20%

Do institutionals & insiders hold more shares of HSTM or OMCL?

69.6% of HealthStream shares are held by institutional investors. Comparatively, 97.7% of Omnicell shares are held by institutional investors. 20.5% of HealthStream shares are held by company insiders. Comparatively, 2.5% of Omnicell shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Is HSTM or OMCL more profitable?

HealthStream has a net margin of 6.84% compared to Omnicell's net margin of 1.13%. HealthStream's return on equity of 5.67% beat Omnicell's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthStream	6.84%	5.67%	3.91%
Omnicell	1.13%	3.82%	2.07%

Which has more volatility and risk, HSTM or OMCL?

HealthStream has a beta of 0.42, indicating that its stock price is 58% less volatile than the S&P 500. Comparatively, Omnicell has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500.

Do analysts prefer HSTM or OMCL?

HealthStream currently has a consensus target price of $32.00, suggesting a potential downside of 4.77%. Omnicell has a consensus target price of $50.67, suggesting a potential upside of 60.87%. Given Omnicell's higher possible upside, analysts plainly believe Omnicell is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthStream	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.80
Omnicell	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

HealthStream beats Omnicell on 10 of the 18 factors compared between the two stocks.